Secondly, emerging evidence suggests that the application of ICIs is associated with more cardiovascular events mediated by the accelerated progression of atherosclerosis (30, 31), which is consistent with a previous study showing that VEGF inhibition disrupts endothelial homeostasis and accelerates atherosclerosis (32). This evidence concerns the gene VEGFA and atherosclerosis.